Get your shred on during Cybersecurity Awareness Month
Paper shred event on Bearcat Commons Oct. 24
Event Information (passed)
The UC Office of Information Security invites all UC students, faculty and staff to drop off personal, work-related and study-related documents at the Cybersecurity Awareness Month shred event.
- When: Tuesday, Oct. 24, 9 a.m.-1 p.m. (or until the truck is full)
- Where: Bearcats Commons, Lot A
- Please note: All metal, including paper clips and hanging file folders, must be removed in advance; staples are permissible. Plastic also needs to be removed — comb bindings, transparencies, Polaroid pictures and Tyvek envelopes. Anything that cannot be torn is not acceptable.
Did you know?
Identity theft affected 49 million Americans and cost $56 billion in 2020 alone. OIS shred events provide a simple and effective way to securely destroy and recycle your professional or personal documents.
Visit the Cybersecurity Awareness Month page for valuable insights and don't forget to participate in our events and activities to win prizes and arm yourself with cybersecurity knowledge.
Related Stories
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.